Skip to content

Opening book details…

About this Medicine article

Re: Jens Bedke, Brian I. Rini, Elizabeth R. Plimack, et al. Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma. Eur Urol. 2022;82:427–39 by Binghao Zhao is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Binghao Zhao
Publisher
Elsevier BV
Published
2022
Language
EN
Field
Medicine (Health Sciences)

More by Binghao Zhao

Browse all works by Binghao Zhao